Furthermore, increased XAF1 expression in resistant cell lines coupled with the inverse correlation of XAF1 expression with GBM survival (Fig. 1e), suggested that XAF1 could contribute to an aggressive phenotype in GBM which is paradoxical to its tumor suppressor role. This evidence concerns the gene XAF1 and glioblastoma.